OncoSec names Brain McCluskey engineering leader

Wednesday, July 6, 2011 10:50 AM

OncoSec Medical has named Brian McCluskey executive director of engineering, to lead the development of the company's proprietary electroporation delivery technology, the OncoSec Medical System (OMS).

McCluskey has more than 30 years of electrical engineering experience, of which he has spent the last 20 years developing software and hardware for devices used for medical and research purposes. He has managed successful submissions for FDA 510(k) approvals, as well as CE marks for marketing in Europe.

Previously McCluskey worked for Teledyne RD Instruments and was engineering manager for Digirad.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs